Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we inform you that a conference call on acquisition of Sandozs dermatology and oral solids businesses is scheduled on 6th September 2018 at 5:30 PM
Please find attached the dial-in details of the call.
In this connection, we enclose herewith the presentation that would be used in the aforesaid conference call.
The presentation is also being uploaded on the website of the Company - http://www.aurobindo.com/investor-relations/investors/investor-presentation
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
